Causative agents of onychomycosis — a retrospective study

JDDG - Journal of the German Society of Dermatology - Tập 4 Số 3 - Trang 218-228 - 2006
Claudia Mügge1, Uwe‐Frithjof Haustein1, Pietro Nenoff1,2
1Clinic for Dermatology,Venerology and Allergology, Leipzig University Clinic
2Laboratory for Medical Microbiology, Mölbis

Tóm tắt

Summary Background: Dermatophytes, yeasts and moulds all are potential causative agents of onychomycosis.The aim of this study was to determine the percentage of cases of onychomycoses caused by each group. In addition, the responsible genus and species was identified for each nail infection. Patients and Methods: In a retrospective study performed at the Department of Dermatology of the Leipzig University, 5 077 nail samples from 4 177 patients – 2 240 women and 1 937 men – with a variety of nail changes – not just onychomycosis – were investigated. 75% were toenails, 23% fingernails, and 2% from both sites. Results: Both microscopic and/or cultural detection of fungi (dermatophytes, yeasts and moulds) were successful in 54% of samples.Causative fungal agents were: 68% dermatophytes, 29% yeast, and 3% moulds. The most frequently detected dermatophyte species were T. rubrum (91%), and T. mentagrophytes (7.7%).Among yeasts, C. parapsilosis (42%) was most common,followed by C. guilliermondii (20.1%), C. albicans (14.2%), and Trichosporon spp. (10%).Scopulariopsis brevicaularis (43%) was the most frequent mould. The percentage of mixed fungal infections was 22%. Conclusions: Dermatophytes, in particular T.rubrum, but also T. mentagrophytes, are the most frequently isolated causative agents in onychomycosis. In addition, yeasts may be isolated relatively frequently, while moulds are uncommon.

Từ khóa


Tài liệu tham khảo

10.1046/j.1365-2133.149.s65.4.x

Mayser P, 2003, Every fifth patient needs antimycotic therapy – Fungal epidemic of the nail bed, MMW Fortschr Med, 145, 30

10.1159/000080853

Korting HC, 2003, Onychomykose – Leitlinie, JDDG Journal der Deutschen Dermatologist Gesellschaft, 1, 74

10.1046/j.1365-4362.1998.00473.x

10.1111/j.1439-0507.1970.tb01260.x

10.1080/13693780410001712043

De Hog GS, 2000, Atlas of clinical fungi

Meinhof W, 1975, Mykosen – Systematik, Klinik, Therapie

10.1007/s001050050531

10.1111/j.1439-0507.1968.tb04457.x

Götz H, 1965, Einblicke in die Epidemiologie der Dermatomykosen im Kohlebergbau, Hautarzt, 16, 543

10.1111/j.1365-2133.1974.tb06363.x

10.1111/j.1365-2133.1966.tb12205.x

10.1046/j.1365-2133.2003.05180.x

10.1111/j.1346-8138.2005.tb00726.x

10.1001/archderm.1972.01620050069017

10.1309/EPH2TDT8335GH0R3

10.1111/j.1365-2133.1973.tb07540.x

10.1067/mjd.2000.107754

10.1111/j.1365-2230.1992.tb00276.x

10.1111/j.1439-0507.1966.tb02659.x

10.1046/j.1439-0507.2000.00547.x

10.1111/myc.1990.33.7-8.411

10.1046/j.1439-0507.2002.00705.x

10.1046/j.1365-4362.1997.00048.x

10.1023/A:1007044720147

Achten G, 1978, Onychomycoses in the laboratory, Mykosen, 125

10.1046/j.1439-0507.1999.00467.x

10.1046/j.1365-4362.1998.00613.x

10.1046/j.1365-4362.1999.00768.x

10.1590/S0074-02762005000200005

10.1111/j.1439-0507.1968.tb03368.x

Effendy I, 2001, Nagelmykosen: Klinik, Diagnose und Therapie

10.1111/j.1439-0507.1967.tb02801.x

10.1046/j.1439-0507.2000.00582.x

Mayser P, 1993, Das Erregerspektrum der Onychomykosen in der Uni.‐Hautklinik Gießen 1987–1992 und dessen potentielle Bedeutung für eine antimykotische Therapie, Zeitschr H+G, 68, 716

Haneke E, 1993, Therapie der Nagelmykosen, Hautarzt, 5, 335

Male O, 1965, Nagelveränderungen durch Schimmelpilze, Dermatol Wschr, 151, 212

10.1007/BF00522751

10.1046/j.1365-2133.1997.d01-1222.x

Meinhof W, 1962, Die Griseofulvinbehandlung der Mykosen

EffendyI.Nagelmykosen – Neue klinische Aspekte als Grundlage für die Behandlung und Prognose mit Berücksichtigung der Epidemiologie Immunologie und Patienten‐Compliance. Habilitationsschrift Universität Marburg 1990.

Abeck D, 1996, Onychomykose: Epidemiologie, Pathogenese, Klinik, Morphologie und Therapie, Dtsch Ärzteblatt, 93, 1432